HLA-DPB1 and leukemia: Indeed, HLA-DPB1 mismatches are associated with increased risks of acute GvHD after 8 of 8 HLA-matched MUD HCT, but also with a significantly reduced risk of leukemia relapse, resulting in no net impact on overall survival (OS) (25).